Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
BOTHELL, WA--(Marketwired - Aug 13, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported...
-
BOTHELL, WA--(Marketwired - Aug 6, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today announced that the...
-
BOTHELL, WA--(Marketwired - Aug 5, 2015) - Marina Biotech, Inc. (OTCQB: MRNA) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CEQ508, an...
-
BOTHELL, WA--(Marketwired - Jun 10, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today announced that the...
-
BOTHELL, WA--(Marketwired - May 14, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported...
-
BOTHELL, WA--(Marketwired - May 5, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today that its...
-
Marina Biotech Expands Global Patent Protection of Clinical Stage Nucleic Acid Delivery Technologies
BOTHELL, WA--(Marketwired - Apr 23, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today it has...
-
BOTHELL, WA--(Marketwired - Feb 25, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported year-end...
-
BOTHELL, WA and SAN DIEGO, CA--(Marketwired - Dec 18, 2014) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, and...
-
BOTHELL, WA--(Marketwired - Dec 9, 2014) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported that its...